4//SEC Filing
Papapetropoulos Spyros 4
Accession 0001213900-25-082904
CIK 0001191070other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 7:02 AM ET
Size
5.8 KB
Accession
0001213900-25-082904
Insider Transaction Report
Form 4
Papapetropoulos Spyros
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (Right-to- Buy)
2025-08-27$8.27/sh+34,559$285,803→ 74,088 totalExercise: $8.27Exp: 2035-08-27→ Common Stock (34,559 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a four-year period at the rate of 2.0833% of the shares of Common Stock on the last day of each month following August 1, 2025 until the options are fully vested.
Documents
Issuer
Neuphoria Therapeutics Inc.
CIK 0001191070
Entity typeother
Related Parties
1- filerCIK 0001832694
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 7:02 AM ET
- Size
- 5.8 KB